Laxxon Medical | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Laxxon Medical

BRIEF

published on 05/22/2024 at 15:10, 5 months 29 days ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE

published on 05/22/2024 at 15:05, 5 months 29 days ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed
BRIEF

published on 05/16/2024 at 15:05, 6 months 4 days ago

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024

3D Printing Technology BIO International Convention Laxxon Medical Pharmaceutical Innovation GLP-1 Agonist
PRESS RELEASE

published on 05/16/2024 at 15:00, 6 months 4 days ago

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Laxxon Medical will showcase LXM.2, a novel 3D printed GLP-1 agonist, at the 2024 BIO International Convention in San Diego, seeking out-licensing or co-development opportunities

BIO International Convention Laxxon Medical GLP-1 Agonist LXM.2 3D Printed
BRIEF

published on 04/23/2024 at 22:45, 6 months 27 days ago

Laxxon Medical to Engage in World Orphan Drug Congress USA 2024

Pharmaceutical Industry 3D Printing Technology Laxxon Medical Orphan Drug Congress Rare Disease
PRESS RELEASE

published on 04/23/2024 at 22:40, 6 months 27 days ago

Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Laxxon Medical to participate in World Orphan Drug Congress USA 2024. Dr. Catherine Gatza to represent the Company at the event in Boston, Massachusetts. Company leveraging SPID®-Technology for pharmaceutical advancements

Laxxon Medical World Orphan Drug Congress USA 2024 SPID®-Technology Pharmaceutical Advancements Drug Delivery Advancements
BRIEF

published on 03/28/2024 at 13:05, 7 months 24 days ago

Laxxon Medical to Join 23rd Annual Needham Virtual Health Conference

Healthcare Innovation Drug Delivery Laxxon Medical Virtual Health Conference Pharmaceutical Technology
PRESS RELEASE

published on 03/28/2024 at 13:00, 7 months 24 days ago

Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical to participate in the 23rd Annual Needham Virtual Health Conference. CEO/Chairman and Chief Strategy Officer will engage with investors. Company focuses on advanced pharmaceuticals with innovative technology

Laxxon Medical Virtual Health Conference Pharma-technology Advanced Pharmaceuticals SPID Technology
PRESS RELEASE

published on 11/06/2023 at 18:00, 1 year ago

Laxxon Medical to Attend BIO-Europe Munich 2023
PRESS RELEASE

published on 07/17/2023 at 15:00, 1 year 4 months ago

Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership

Accesswire

Published on 11/21/2024 at 14:15, 7 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 22 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 22 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 22 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 22 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 6 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 7 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 22 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 7 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 47 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 24 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 2 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 37 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 37 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE